Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-t82dr Total loading time: 0.313 Render date: 2021-12-01T01:22:21.028Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

1 - Emerging medical technologies: high stakes science and the need for technology assessment

Published online by Cambridge University Press:  05 June 2012

Rebecca Richards-Kortum
Affiliation:
Rice University, Houston
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Health in the Millenium Development Goals: Millenium Development Goals, Targets and Indicators Related to Health. World Health Organization; 2004.
Glossary of Globalization, Trade and Health Terms: Health Transition. World Health Organization; 2007.
Beaglehole, R, Irwin, A, Prentice, T. The World Health Report 2004: Changing History. Geneva, Switzerland: The World Health Organization; 2004.Google Scholar
Coulter, SL, Cecil, B. Assessing the Value of Health Care in Tennessee. Chattanooga: Blue Cross Blue Shield of Tennessee; 2003.Google Scholar
Breast Cancer Facts and Figures 2005–2006. Atlanta, GA: American Cancer Society, Inc.; 2005. http://www.cancer.org/downloads/STT/CAFF2005BrF.pdf
Peters, WP, Ross, M, Vredenburgh, JJ, Meisenberg, B, Marks, L, Winer, E, et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology. 1993 June; 11(6): 1132–43.CrossRefGoogle ScholarPubMed
Groopman, J. Bone marrow transplant: a healing hell. The New Yorker. 1998 October 19: 34–9.Google Scholar
Mello, MM, Brennan, TA. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Affairs (Project Hope). 2001 Sep–Oct; 20(5): 101–17.CrossRefGoogle ScholarPubMed
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence – SEER 13 Regs Public-Use, Nov 2005 Sub (1992–2003) and SEER 9 Regs Public-Use, Nov 2005 Sub (1973–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality – All COD, Public-Use With State, Total U.S. for Expanded Races/Hispanics (1990–2003) and All COD, Public-Use With State, Total U.S. (1969–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
Silverthorn, DU. Human Physiology: An Integrated Approach. 2nd edn. Upper Saddle River, NJ: Prentice Hall; 2001.Google Scholar
,American Cancer Society. Detailed Guide: Breast Cancer: How is Breast Cancer Staged? Sep 18 2006 [refd 2007]. Available from: http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_How_is_breast_cancer_staged_5.asp
Walker, F, Roethke, SK, Martin, G. An overview of the rationale, process, and nursing implications of peripheral blood stem cell transplantation. Cancer Nursing. 1994 Oct 10; 17(2): 141–8.CrossRefGoogle ScholarPubMed
Hansson, M, Svensson, A, Engervall, P. Autologous peripheral blood stem cells: collection and processing. Medical Oncology. 1996 Jun; 13(2): 71–9.CrossRefGoogle Scholar
Leukemia, Lymphoma, Myeloma, Facts and Statistics 2006–2007. White Plains, NY: Leukemia and Lymphoma Society; 2007.
White, K. Notebook: bone marrow transplant for breast cancer is questioned on basis of incomplete data. Journal of Women's Health and Gender-Based Medicine. 1999; 8(5): 577–82.CrossRefGoogle Scholar
Brockstein, BE, Williams, SF. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today, and tomorrow. Stem Cells. 1996; 14: 79–89.CrossRefGoogle Scholar
Abegunde, D, Beaglehole, R, Durivage, S, Epping-Jordan, J, Mathers, C, Shengelia, B, et al. Preventing Chronic Diseases: A Vital Investment. Geneva, Switzerland: World Health Organization; 2005.Google Scholar
Aetna, . Breast cancer: high-dose chemotherapy with autologous stem cell support. Clinical Policy Bulletins 2005 October 5 [available from: http://www.aetna.com/cpb/data/CPBA0507.html].Google Scholar
Bezwoda, WR, Seymour, L, Dansey, RD. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology. 1995 Oct; 13(10): 2483–9.CrossRefGoogle ScholarPubMed
Tallman, MS, Gray, R, Robert, NJ, LeMaistre, CF, Osborne, CK, Vaughan, WP, et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. The New England Journal Of Medicine. 2003 Jul 3; 349(1): 17–26.CrossRefGoogle ScholarPubMed
Bezwoda, WR. Randomised, controlled trial of high dose chemotherapy versus standard dose chemotherapy for high risk, surgically treated, primary breast cancer. Proceedings of the American Society of Clinical Oncology. 1999; 18: 2a.Google Scholar
Grady, D. Doubts raised on a breast cancer procedure. New York Times. 1999 April 16; Sect. A1.Google Scholar
Silberner, J. Morning Show: breast cancer. National Public Radio. 1999 April 16. http://www.npr.org/templates/story/story.php?storyId=1049404.
Anthem, . Insurance payments for bone marrow transplantation in metastatic breast cancer. The New England Journal of Medicine. 2000 April 13; 342(15): 1138–9.Google Scholar
New audit uncovers scientific misconduct in 1995 South African study on metastatic breast cancer. American Society of Clinical Oncology. 2001 April 26.
Horton, R. After Bezwoda. Lancet. 2000 Mar 18; 355(9208): 942–3.CrossRefGoogle ScholarPubMed
Rodenhuis, S, Bontenbal, M, Beex, LV, Wagstaff, J, Richel, DJ, Nooij, MA, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. The New England Journal Of Medicine. 2003 Jul 3; 349(1): 7–16.CrossRefGoogle ScholarPubMed
Stadtmauer, EA, O'Neill, A, Goldstein, LJ, Crilley, PA, Mangan, KF, Ingle, JN, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. The New England Journal of Medicine. 2000 Apr 13; 342(15): 1069–76.CrossRefGoogle ScholarPubMed
Antman, KH. Randomized trials of high dose chemotherapy for breast cancer. Biochimica Et Biophysica Acta. 2001 Mar 21; 1471(3): M89–98.Google ScholarPubMed
Frazier, HS, Mosteller, F. Medicine Worth Paying For: Assessing Medical Innovations. Cambridge, Mass.: Harvard University Press; 1995.Google Scholar
Ioannidis, JP. Contradicted and initially stronger effects in highly refd clinical research. JAMA: The Journal Of The American Medical Association. 2005 Jul 13; 294(2): 218–28.CrossRefGoogle ScholarPubMed
Face to Face with Chronic Desease: Maria's Story: Fighting Cancer. World Health Organization, 2005.
Mello, M. M. and Brennan, T. A.. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Affairs, 20:5 (2001), 101–17CrossRefGoogle ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×